Low-Dose Vismodegib as Maintenance Therapy After Locally Advanced Basal Cell Carcinoma Complete Remission: High Efficacy with Minimal Toxicity

Abstract Introduction Locally advanced basal cell carcinoma (laBCC) has always represented an uncommon, difficult-to-treat form of skin cancer, but approval of the Hedgehog inhibitor (HHI) vismodegib has provided an effective, well-tolerated therapy. While this drug has been shown to be a safe and e...

Full description

Saved in:
Bibliographic Details
Main Authors: Massimiliano Scalvenzi (Author), Milena Cappello (Author), Claudia Costa (Author), Gabriella Fabbrocini (Author), Mariaantonietta Luciano (Author), Alessia Villani (Author)
Format: Book
Published: Adis, Springer Healthcare, 2020-04-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available